Skip to main content
Fig. 3 | BMC Endocrine Disorders

Fig. 3

From: Cost effectiveness and value of information analyses of islet cell transplantation in the management of ‘unstable’ type 1 diabetes mellitus

Fig. 3

Cost-Effectiveness Acceptability Frontiers (CEAFs). The CEAFs are for scenarios with different discount rates: 0 % (doted line), 3 % (short-dashed line), 3.5 % (long-dashed line) and 5 % (solid line). The dents in CEAFs, with their lowest points indicating the willingness-to-pay levels when islet transplantation becomes the net benefit maximizing alternative, move to higher WTP levels when using higher discount rates

Back to article page